切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - NTPDases - Na /Ca2 Exchangers (NCXs) - Voltage-gated Potassium (KV) Channels

10 件产品

每页
清除全部
  1. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  2. PSB 06126
    B7113 PSB 06126
    Target: NTPDases
    Summary: NTPDase 3抑制剂
      <46.64 mg/mL
      <23.32 mg/mL
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  5. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  6. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  7. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  8. SEA0400
    A3811 SEA0400
     4 Citation
    Target: Na /Ca2 Exchangers (NCXs)
    Summary: 特异性的Na+/Ca2+交换抑制剂
      ≥18.57 mg/mL
      insoluble in H2O
  9. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  10. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O

10 件产品

每页